| 标题： | 中华医学会肺癌临床诊疗指南（2020版） |
| title： | Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2020 edition) |
| 版本： | 更新版 |
| version： | Updated |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 各级临床医务人员 |
| Guide users： | Health care workers |
| 证据分级方法： | Category 1 Based upon high-level evidence, there is a uniform consensus of the Expert Committee that the intervention is appropriate. Category 2A Based upon lower-level evidence, there is a uniform consensus of the Expert Committee that the intervention is appropriate. Category 2B Based upon lower-level evidence, there is a consensus of the Expert Committee that the intervention is appropriate. Category 3 Based upon any level of evidence, there is a major disagreement of the Expert Committee that the intervention is appropriate. |
| Evidence grading method： | |
| 制定单位： | 中华医学会肺癌临床诊疗指南（2020版）专家委员会 |
| Formulating unit： | the Expert Committee of Chinese Medical Association guidelines for clinical diagnosis and treatment of lung cancer (2020 edition) |
| 注册时间： | 2021-03-23 |
| Registration time： | |
| 注册编号： | IPGRP-2021CN058 |
| Registration number： | |
| 指南制订的目的： | 为进一步规范我国肺癌防治措施、提高肺癌的诊疗水平、改善患者的预后，并给各级临床医务人员提供肺癌筛查、诊断、病理、治疗和随访等方面的推荐意见。 |
| Purpose of the guideline： | For standardizing the diagnosis and management, improving the prognosis of lung cancer, and providing authoritative guidance in screening, diagnosis, pathological typing, treatment, and follow-up of lung cancer for health workers. |
最新注册
